Expression and purification of recombinant soluble tissue factor
AssigneeOklahoma Medical Research Foundation
InventorsAlireza Rezaie, Charles T. Esmon, James H. Morrissey
Life of this patent
Estimating the term…
Loading patent…
AssigneeOklahoma Medical Research Foundation
InventorsAlireza Rezaie, Charles T. Esmon, James H. Morrissey
Estimating the term…
A method is disclosed to make any protein in a form that can be isolated rapidly from a solution using a specific monoclonal antibody designated "HPC-4". It has now been determined that it is possible to form a fusion protein of the epitope with a protein to be isolated, and isolate the protein using HPC-4-based affinity chromatography. In the preferred embodiment, a specific protease cleavage site is inserted between the epitope and the protein so that the epitope can be easily removed from the isolated protein. In an example, a functionally active soluble tissue factor including the twelve amino acid epitope recognized in combination with calcium by HPC-4 and a factor Xa cleavage site was expressed from a vector inserted into a procaryotic expression system. The recombinant tissue factor can be rapidly isolated in a single chromatographic step using the HPC-4 monoclonal antibody immobilized on a suitable substrate. Once isolated, the Protein C epitope is removed by cleavage with factor Xa, leaving the functionally active, soluble tissue factor.
A fusion protein comprising an epitope which is capable of binding in the presence of calcium to the monoclonal antibody designated as HPC-4 (ATCC No. HB 9892) and a protein to be isolated by binding of the fusion protein to HPC-4 antibody, wherein the epitope and the protein to be isolated are separated by a specific protease cleavage site.
Dependencies are inferred from the claim text.